Background: Chronic inflammatory demyelinating polyradiculoneuropathy is a rare acquired immune-mediated progressive or relapsing disorder causing peripheral neuropathic disease of duration more ...

Keyword search terms used were; "chronic inflammatory demyelinating polyneuropathy" or "CIDP" or "chronic inflammatory polyneuropathy" or "autoimmune neuropathies" combined with "drug therapy" or ...

erasmusmc.nl Guillain-Barré syndrome (GBS) is an acute polyradiculoneuropathy with a highly ... signs of demyelination on nerve conduction studies, acute-onset chronic inflammatory demyelinating ...

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) and argenx (Euronext & Nasdaq: ARGX) today announced that China’s National Medical ...

000mg (5.6ml)/vial [efgartigimod alfa injection (subcutaneous injection)] for the treatment of adult patients with chronic inflammatory demyelinating polyneuropathy (CIDP). VYVGART Hytrulo is ...

A research team has developed a new class of oral peptide therapeutic leads for treating chronic abdominal pain ... irritable bowel syndrome (IBS) and inflammatory bowel diseases (IBD), which ...

Phase 3 NEAT clinical trial on track with 32 patients enrolled to date with majority of U.S. and European study sites now ...

Phase 3 NEAT clinical trial on track with 32 patients enrolled to date with majority of U.S. and European study sites now enrolling patients Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage ...